register

News & Trends - Pharmaceuticals

MOGA and Novartis applaud 2021 recipient of the Cancer Achievement Award

Health Industry Hub | July 30, 2021 |

Pharma News: The Medical Oncology Group of Australia (MOGA) and Novartis Oncology Cancer Achievement Award recognises outstanding contributions made by scientists, clinicians and other health professionals to cancer research and control in Australia.

Since 1999 this Award has been presented to 21 leaders in the field of Australian Oncology. 

In 2021 the Award will be presented at the Opening Ceremony for the Annual Scientific Meeting by this year’s recipient, Professor Clare Scott who will deliver the Award Address on Thursday 5 August.

“On behalf of Novartis Oncology, I would like to congratulate Professor Scott  for her remarkable achievements in research of ovarian and rare cancers, and improvement of patient outcomes. A very well-deserved award, representing considerable contributions towards the progress of medical care in this field,” said Dr Othon Gervasio, Medical Director, Novartis Group (Australia and New Zealand).

Professor Scott receives the Award for her meritorious contribution as a medical oncology clinician, clinician-researcher, leader and mentor. Clare Scott is Professor of Gynaecological Cancer Obstetrics and Gynaecology Royal Women’s Hospital/Mercy, University of Melbourne and Joint Division Head Division Clinical Translation, ACRF Cancer Biology and Stem Cells at The Walter and Eliza Hall Institute of Medical Research in Melbourne. Her dedication to rare and ovarian cancers research over the last decade has contributed significantly to the establishment of platforms whereby clinical, research and consumer organisations can collaborate to impact on rare cancer survivorship. Professor Scott’s skills in clinical oncology, evidence-based medicine and research have resulted in the leadership of numerous, influential clinical trials. 


News & Trends - MedTech & Diagnostics

$54 million cancer centre opens in one of Australia’s fastest growing communities

Health Industry Hub | March 28, 2024 |

MedTech & Diagnostics News: Cancer care provider, GenesisCare, is now treating patients at a new $54 million integrated cancer centre […]

More


Marketing & Strategy

Bayer, MSD and Takeda among winners at Asia Pacific awards

Bayer, MSD and Takeda among winners at Asia Pacific awards

Health Industry Hub | March 28, 2024 |

Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]

More


News & Trends - MedTech & Diagnostics

Queensland elevates diagnostic precision with cutting-edge imaging technology

Queensland elevates diagnostic precision with cutting-edge imaging technology

Health Industry Hub | March 28, 2024 |

MedTech & Diagnostics News: Mackay Base Hospital and Qscan Mackay have unveiled state-of-the-art medical imaging machines to elevate patient care […]

More


News & Trends - Pharmaceuticals

Landmark collaboration sparks inauguration of precision care clinic

Landmark collaboration sparks inauguration of precision care clinic

Health Industry Hub | March 28, 2024 |

Pharma News: In a landmark collaboration, Australians with cancer will receive more personalised care through the newly established Precision Care […]

More


This content is copyright protected. Please subscribe to gain access.